Loading...
Becton, Dickinson and Company
BDX•NYSE
HealthcareMedical - Instruments & Supplies
$165.15
$-1.85(-1.11%)
Becton, Dickinson and Company (BDX) AI-Powered Stock Analysis
See how Becton, Dickinson and Company scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerBecton, Dickinson and Company (BDX) Stock Overall Grade
Becton, Dickinson and Company’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B+
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Becton, Dickinson and Company's overall stock rating.
Forecast
A+Score
100/100Financial Growth
BScore
60/100Fundamental Growth
AScore
84/100Key Ratios
B+Score
70/100Sector Comparison
B+Score
75/100Industry Comparison
AScore
80/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
B+Score
75/100Component Analysis Explained
Understand the key factors behind each Becton, Dickinson and Company stock grade, including financials, comparisons, and forecasts.